Biophagy’s Proprietary Drug Developmentjordan2022-01-21T21:33:49+00:00
Biophagy’s Proprietary Drug Development
Proprietary Drug Discovery Program
Biophagy is positioned as a discovery pharmaceutical company currently developing its proprietary drug development program in three separate areas. Its goal is to bring lead compounds into pre-clinical development and to partner with a larger company for advanced testing and clinical trials.
Chemical libraries encompass compounds active in tuberculosis, SARS-CoV-2 (covid-19), and neurodegenerative diseases. Biophagy intends to look for utility in additional applications with unmet medical needs.
Biophagy has developed this early program in collaboration with the following outstanding institutions: